PatientsLikeMe ™

all
Join Now (It's free!)

Already a member? Log in

Share your real-world treatment experience
with patients just like you.
Select a community
All Communities

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


What is Mestinon? Mestinon is a brand name for the drug Pyridostigmine, a cholinesterase inhibitor used for the treatment of muscle weakness in Myaesthenia Gravis. Mestinon is a brand name owned by Valeant pharmaceuticals. Read more...Click to read more below

Valeant's Mestinon site


Reasons Taken

16 patients in the community are taking or have taken Mestinon.

Dosages

Based on the patients currently taking Mestinon.

  30 mg As needed 60 mg As needed 2 other Daily 20 mg Daily 40 mg Daily 60 mg Daily 80 mg Daily 120 mg Daily 180 mg Daily 300 mg Daily
  1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1  

Duration

How long current patients have been taking Mestinon or how long patients were taking Mestinon before stopping.

Currently taking Mestinon

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
2
0
2
1
4

Stopped taking Mestinon

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
1
0
0
1
0
Why Patients Stopped Taking Mestinon (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 2 100% Did not seem to work: 100%
Doctor's advice 1 50% Doctor's advice: 50%

Patient Reported Evaluations

Results from 2 patient evaluations. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

Major 100% 1

Fatigue

Side-effects (as an overall problem)

Severe 0% 0
Moderate 0% 0
Mild 0% 0
None 100% 2

Top reported side-effects include:

Summary results are based on 2 individual responses. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (1 of 2)

  • ashfieb
    Sex: M
    Mouth/throat: none
    Arms: mild
    Chest: none
    Legs: none
  • ashfieb
  • by ashfieb
    Aug 19, 2008
  • EfficacyNone
  • Side-effectsNone
  • Atrophy, upper body muscles

See all evaluation results for Mestinon



Back to top